Johnson & Johnson News Headlines

JNJ 
$105.244
*  
0.654
0.63%
Get JNJ Alerts
*Delayed - data as of Dec. 26, 2014 11:42 ET  -  Find a broker to begin trading JNJ now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    JNJ Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Stocks Reverse Early Weakness To Show Modest Gains - U.S. Commentary
9/30/2014 11:00:00 AM - RTT News


Retirees, You CAN Count On Dividend Stocks To Deliver From Here
9/30/2014 9:54:00 AM - Seeking Alpha


Johnson & Johnson To Buy Privately-held Alios BioPharma For $1.75 Bln Cash
9/30/2014 9:13:00 AM - RTT News


Johnson & Johnson To Buy Privately-Held Alios BioPharma For Nearly $1.75 Bln
9/30/2014 8:41:00 AM - RTT News


Gilead Sciences, Inc. Stock's Stunning New Opportunity
9/30/2014 8:15:02 AM - Motley Fool


Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for October 01, 2014
9/30/2014 8:00:02 AM - NASDAQ.com News


Cintas Beats on Q1 Earnings with Robust Margin Expansion - Analyst Blog
9/30/2014 8:00:00 AM - Zacks.com


Roche Releases Data from CLEOPATRA Study on Perjeta - Analyst Blog
9/29/2014 3:50:00 PM - Zacks.com


Notable ETF Inflow Detected - XLV, JNJ, AMGN, BMY
9/29/2014 9:52:48 AM - BNK Invest


Better Dividend Stock: Johnson & Johnson or Pfizer, Inc?
9/29/2014 7:51:42 AM - Motley Fool


Retirement Strategy: The 'Buy The Dips Portfolio' Had A Blah Month, But There Are A Few New Opportunities Right Now
9/29/2014 12:01:00 AM - Seeking Alpha


Prostate Cancer Incidence Is the Highest in These 5 States
9/28/2014 10:47:02 AM - Motley Fool


'Tax Inversions' Are Tip Of An Iceberg That Already Cost The U.S. Treasury Hundreds Of Billions
9/28/2014 2:50:00 AM - Seeking Alpha


Retirement Strategy: ETF Only Portfolio Vs. Buy The Dips Portfolio - A Dreary September Update
9/28/2014 12:01:00 AM - Seeking Alpha


How To Measure The Potential For Surprise In An Earnings Report If You Wish To Design A Related Trade
9/27/2014 9:46:00 PM - Seeking Alpha


The Single Biggest Risk in Retirement -- and How to Avoid It
9/27/2014 6:00:03 AM - Motley Fool


Allergan Writes Back, Coaxes Shareholders Against Valeant - Analyst Blog
9/26/2014 4:00:00 PM - Zacks.com


Gilead's HIV Drugs Tybost and Vitekta Get FDA Clearance - Analyst Blog
9/26/2014 3:30:00 PM - Zacks.com


Roche Announces Positive Results from Studies on Avastin - Analyst Blog
9/26/2014 12:00:00 PM - Zacks.com


Will Cintas (CTAS) Disappoint this Earnings Season? - Analyst Blog
9/26/2014 8:20:00 AM - Zacks.com


Let's Talk About The Nifty Fifty And Dividend Growth Investing
9/25/2014 9:23:00 PM - Seeking Alpha


Inovio/GeneOne Life Science Collaborate for Ebola Vaccine - Analyst Blog
9/25/2014 4:00:00 PM - Zacks.com


Valeant (VRX) Sends Letter to Allergan, Provides Q3 Update - Analyst Blog
9/25/2014 3:38:00 PM - Zacks.com


Why Organovo Holdings Inc Stock Crashed By 40% in 2014
9/25/2014 1:28:45 PM - Motley Fool


How A Company Like Procter & Gamble Can Save Your Retirement
9/25/2014 10:44:00 AM - Seeking Alpha